Effects of Gestational Weight Gain on Delivery Outcomes in an Obese, Low-Income Population
Allison Archer Sellner1, Abigail Hook Garbarino1, Di Miao1
1From the Department of Obstetrics and Gynecology, Baylor College of Medicine, and Texas Children's Health Plan, Houston, Texas.
Objective:
To examine the effects of weight gain/loss on delivery outcomes stratified by class of obesity in an obese, low-income, predominantly minority population.
Methods:
A retrospective review of a cohort of 1428 women receiving care at a large Medicaid clinic from 2013 to 2016 with pregravid body mass index ≥30 was conducted. Multinomial logistic regression analysis was used to compare differences in gestational weight change to the primary outcomes of birth-weight percentile and delivery type and secondary outcomes of preterm delivery, preterm labor, gestational diabetes mellitus, and gestational hypertension.
Results:
Obesity class 1 patients who lost weight were more likely to have a small-for-gestational-age (SGA) infant compared with those who had recommended weight gain. Obesity classes 2 and 3 patients had no statistically significant increase in SGA infants with weight loss or weight gain below current recommendations. Obesity classes 1 and 2 patients with weight loss had a statistically significant increase in both preterm delivery and preterm labor; however, class 3 patients did not. Obesity class 3 patients who lost weight were significantly more likely to have gestational diabetes mellitus.
Conclusions:
Obesity class 3 women may benefit from less weight gain than current recommendations without increasing their risk of SGA infants or preterm birth, especially if gestational diabetes mellitus is present.
Related Concept Videos
Drug Dosing: Obese Patients
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Diabetes Mellitus: Type 2 and Gestational
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion


